1. Home
  2. SLNG vs ANIX Comparison

SLNG vs ANIX Comparison

Compare SLNG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stabilis Solutions Inc.

SLNG

Stabilis Solutions Inc.

HOLD

Current Price

$3.69

Market Cap

103.2M

Sector

Utilities

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.93

Market Cap

100.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLNG
ANIX
Founded
2013
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
103.2M
100.6M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
SLNG
ANIX
Price
$3.69
$2.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$10.00
$8.67
AVG Volume (30 Days)
22.7K
112.2K
Earning Date
05-06-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
2400.00
12.82
EPS
N/A
N/A
Revenue
$68,245,000.00
$210,000.00
Revenue This Year
$8.66
N/A
Revenue Next Year
$14.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.21
$2.44
52 Week High
$6.36
$5.46

Technical Indicators

Market Signals
Indicator
SLNG
ANIX
Relative Strength Index (RSI) 42.06 49.02
Support Level $3.25 $2.74
Resistance Level $4.90 $3.12
Average True Range (ATR) 0.33 0.17
MACD 0.00 -0.01
Stochastic Oscillator 27.48 23.05

Price Performance

Historical Comparison
SLNG
ANIX

About SLNG Stabilis Solutions Inc.

Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: